For unbiased identification of proteases that sensitize murine breast cancer cells to PI3K inhibition we used RNAi screens in which protease-targeted murine breast cancer cells were subjected to two PI3K pathway inhibitors (Figure 2). The gene discussed is PIK3CA; the disease is breast cancer.